Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700855 | European Journal of Surgical Oncology (EJSO) | 2017 | 7 Pages |
Abstract
A prediction tool based on five parameters, including the biomarker S-100B, showed accurate risk stratification for NSN-involvement in SN-positive melanoma patients. If validated in future studies, this tool could help to identify patients with low risk for NSN-involvement.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Damude, K.P. Wevers, R. Murali, S. Kruijff, H.J. Hoekstra, E. Bastiaannet,